Completed Lungs & Breathing Cells, Biochemistry & Physiology

Mechanisms of Fibre Toxicity (cross-Unit project)

In plain English

AI plain-English summary

Carbon nanotubes used in modern manufacturing are physically similar to asbestos, and researchers are now tracking how these tiny particles trigger disease in the body. The problem is that asbestos-related diseases such as mesothelioma and lung cancer take 20 to 40 years to appear after exposure, meaning any harm from nanoparticles could remain hidden for decades. Current safety testing cannot predict long-term toxicity quickly enough to keep pace with new materials entering production. This project applies cutting-edge technologies to identify the specific biological mechanisms that turn a harmless particle into a dangerous one. If the research succeeds, manufacturers could redesign nanoparticles to be “safe by design” before they reach factories and consumers. That would reduce the risk of a future wave of lung disease similar to the one caused by asbestos, without slowing innovation in materials science, electronics, or medical devices. The work is primarily fundamental toxicology—understanding exactly how fibre shape, size, and chemistry drive harm—but the practical payoff would be a faster, more reliable way to screen new materials for long-term safety.

View original technical description
A major research focus of the MRC Toxicology Unit aims to uncover how particles used for modern manufacturing interact with the body and how to help prevent their harmful effects. Some of these particles (e.g. carbon nanotubes) are similar in their physical and biological properties to asbestos, a well-known cause of human lung disease. The most severe illnesses associated with asbestos fibre exposure are asbestosis, malignant mesothelioma and lung cancer, and they usually manifest themselves after 20-40 years of latency. There is rising concern that nanoparticles may drive toxic effects leading to the onset of similar asbestos-related diseases. By applying cutting-edge technologies to this toxicological question the aim is to identify potential key drivers of particle toxicity and apply this knowledge to inform ‘safe by design’ of nanoparticles, thereby reducing their potential long-term adverse effects.

View the original record at the funder ↗

Researchers

Anne Willis (Principal Investigator)Marion MacFarlane (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Carbon Nanotubes and the Asbestos/Fibre Structure Activity Relationship
Persistent micro- and nanoplastics as triggers for interstitial lung disease
Environment and Health: Influence of Microplastic and Nanoplastics on Lung Cells
In vitro modelling of lung response to environmental nanoparticulates
Application of in vitro and zebrafish models to investigate nanomaterial mediated pulmonary fibrosis

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.